Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu
Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu
View: Text | PDF
Research Article Pulmonology

Monocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution

  • Text
  • PDF
Abstract

Recent studies have presented compelling evidence that it is not tissue-resident, but rather monocyte-derived alveolar macrophages (TR-AMs and Mo-AMs, respectively) that are essential to development of experimental lung fibrosis. However, whether apolipoprotein E (ApoE), which is produced abundantly by Mo-AMs in the lung, plays a role in the pathogenesis is unclear. In this study, we found that pulmonary ApoE was almost exclusively produced by Mo-AMs in mice with bleomycin-induced lung fibrosis. We showed that, although ApoE was not necessary for developing maximal fibrosis in bleomycin-injured lung, it was required for the resolution of this pathology. We found that ApoE directly bound to Collagen I and mediated Collagen I phagocytosis in vitro and in vivo, and this process was dependent on low-density lipoprotein receptor–related protein 1 (LPR1). Furthermore, interference of ApoE/LRP1 interaction impaired the resolution of lung fibrosis in bleomycin-treated WT mice. In contrast, supplementation of ApoE promoted this process in ApoE–/– animals. In conclusion, Mo-AM–derived ApoE is beneficial to the resolution of lung fibrosis, supporting the notion that Mo-AMs may have distinct functions in different phases of lung fibrogenesis. The findings also suggest a potentially novel therapeutic target for treating lung fibrosis, to which effective remedies remain scarce.

Authors

Huachun Cui, Dingyuan Jiang, Sami Banerjee, Na Xie, Tejaswini Kulkarni, Rui-Ming Liu, Steven R. Duncan, Gang Liu

×

Figure 7

Interference of ApoE/LRP1 interaction impairs the resolution of pulmonary fibrosis.

Options: View larger image (or click on image) Download as PowerPoint
Interference of ApoE/LRP1 interaction impairs the resolution of pulmonar...
(A) Six-week-old WT male mice were i.t. instilled with bleomycin (BLM, 1.5 U/kg in 50 μL saline). Starting at 4 weeks after bleomycin treatment, mice were administered i.t. COG133 (1 mg/kg in 50 μL saline) or saline alone, once every other day. Mice were sacrificed at 8 weeks after bleomycin injection for fibrosis evaluation. (B) The levels of hydroxyproline in the lungs were determined. (C) Total RNAs of the lungs were purified, and the expression of the indicated genes was assessed by real-time PCR. (D and E) BALF protein was precipitated and resolved by SDS-PAGE. Levels of the indicated proteins in BALF were determined by Western blotting (D) and densitometric analyses performed using ImageJ (E). n = 6, 5; mean ± SEM; *P < 0.05, **P < 0.01, ***P < 0.001 by 2-tailed Student’s t test (B–E).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts